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Autoimmune Link
To assess the risk of psoriasis 
in patients with celiac 
disease (CD), Ludvigsson 
and colleagues examined a 
population-based sample of 
nearly 29,000 individuals with 
biopsy-verified CD. This study 
revealed an increased risk of 
psoriasis in CD patients both 
before and after diagnosis of 
CD. In fact, 42% of all psoriasis 
in patients with CD was 
attributable to the underlying 
CD. The large sample size 
allowed confirmation of an 
increased risk in all age strata 
and after more than five years 





the preferred therapy for 
discoid lupus erythematosus 
(DLE); however, a recent 
multicenter observational 
and pharmacogenetic cohort 
study of 200 DLE patients 
by Wahie and colleagues 
demonstrated that 39% of 
these patients either were 
nonresponders or developed 
toxicity to this drug. Localized 
disease and absence of 
concomitant systemic LE (SLE) 
were significantly associated 
with a positive response 
to this drug. Interestingly, 
neither cytochrome P450 
genotype nor smoking 
status exhibited a significant 
influence on response to 
hydroxychloroquine in these 
patients. A future prospective 
study is needed to determine 
whether baseline disease 
severity and/or associated SLE 
effectively predict response to 
hydroxychloroquine.  
See page 1981
Covering All the Bases
Cullinane and colleagues employed single-
 nucleotide polymorphism array analysis, homo-
zygosity mapping, and whole-exome sequencing 
to diagnose a syndromic, multisystemic pigmen-
tary disorder in a consanguineous female who 
presented with oculo cutaneous albinism (OCA) 
and neutropenia in concert with other symp-
toms. Homozygous variants were identified in 
SLC45A2, a gene associated with OCA type 
4, and in G6PC3, a gene involved in neutro-
penia. The pathogenic SLC45A2 mutation resulted in reduced, mis localized protein 
in melanocytes and secretion of the tyrosinase into the culture medium. The mutation 
in G6PC3 resulted in decreased expression and increased fibroblast apoptosis. This 
report highlights the utility of using these molecular approaches to make an otherwise 
difficult diagnosis. See page 2017  
Calling on Man’s Best Friend
Delivery of exogenous wild-type collagen 
type VII (Col7) to recessive dystrophic epi-
dermolysis bullosa (RDEB) cells has proven 
effective at reversing the pathology; however, 
the short life span of RDEB mice precludes 
examination of the long-term effects of such 
therapy. Gache and colleagues demonstrated 
successful ex vivo gene therapy via engraft-
ment of genetically engineered RDEB skin 
onto a golden retriever dog with mild RDEB. 
This therapy was dependent on highly effi-
cient transduction of the keratinocytes and 
sustained expression of Col7. This dog model 
allowed long-term assessment of the efficacy 
of treatment, and the results support the fea-
sibility of an ex vivo gene therapy approach 
for this disease in humans. See page 2069
The Rate of Healing
To identify clinical variables related to wound heal-
ing in a population of diabetics, Christman and 
colleagues compared wound-healing rates and 
hemoglobin A1c (HbA1c), a standard measure of 
glycemia, in 183 individuals with diabetes. Indeed, 
elevated HbA1c was significantly associated 
with a poor wound healing rate, but other clini-
cal, laboratory, and demographic variables were 
not. Hyperglycemia is thus associated with slower 
wound healing, especially in neuropathic foot 
wounds and in patients with peripheral artery disease. These data suggest that HbA1c 
is an important clinical predictor of wound healing rate. See page 2121
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